Single Patient Safety Concern Hits Allogene’s Off-The-Shelf CAR-T

All Of Company’s Trials Halted

 
• By Andrew McConaghie
  
Allogene building
The first autologous CAR-Ts gained approval in 2017, but the wait for the first allogeneic version goes on.

More from Business

More from Scrip